Results from phase II trial of enzastaurin (LY317615) in patients with recurrent high grade gliomas.

被引：0
|
作者：
Fine, HA
Kim, L
Royce, C
Draper, D
Haggarty, I
Ellinzano, H
Albert, P
Kinney, P
Musib, L
Thornton, D
机构：
[1] NCI, Neurooncol Branch, NIH, Bethesda, MD 20892 USA
[2] NINDS, NIH, Bethesda, MD 20892 USA
[3] NCI, Biometr Branch, Bethesda, MD 20892 USA
[4] Eli Lilly, Indianapolis, IN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：115S / 115S
页数：1
相关论文
共 50 条
  • [1] A phase II trial of LY317615 in patients with recurrent high grade gliomas.
    Fine, HA
    Kim, L
    Royce, C
    Mitchell, S
    Duic, JP
    Albert, P
    Musib, L
    Thornton, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 109S - 109S
  • [2] A PHASE I TRIAL OF ENZASTAURIN (LY317615) IN PATIENTS WITH RECURRENT GLIOMAS
    Kreisl, Teri
    Kim, Lyndon
    Heinrich, Elinzano
    Royce, Cheryl
    Stroud, Irene
    Nancy, Garren
    Albert, Paul
    Musily, Luna
    Thornton, Donald E.
    Fine, Howard
    [J]. NEURO-ONCOLOGY, 2008, 10 (05) : 786 - 786
  • [3] A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
    Odia, Yazmin
    Iwamoto, Fabio M.
    Moustakas, Argirios
    Fraum, Tyler J.
    Salgado, Carlos A.
    Li, Aiguo
    Kreisl, Teri N.
    Sul, Joohee
    Butman, John A.
    Fine, Howard A.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2016, 127 (01) : 127 - 135
  • [4] A phase II trial of enzastaurin (LY317615) in combination with bevacizumab in adults with recurrent malignant gliomas
    Yazmin Odia
    Fabio M. Iwamoto
    Argirios Moustakas
    Tyler J. Fraum
    Carlos A. Salgado
    Aiguo Li
    Teri N. Kreisl
    Joohee Sul
    John A. Butman
    Howard A. Fine
    [J]. Journal of Neuro-Oncology, 2016, 127 : 127 - 135
  • [5] A phase I study of LY317615 (enzastaurin) and temozolomide in patients with gliomas (EORTC trial 26054)
    Rampling, Roy
    Sanson, Marc
    Gorlia, Thiery
    Lacombe, Denis
    Lai, Christina
    Gharib, Myriam
    Taal, Walter
    Stoffregen, Clemens
    Decker, Rodney
    van den Bent, Martin J.
    [J]. NEURO-ONCOLOGY, 2012, 14 (03) : 344 - 350
  • [6] Phase 1 study of LY317615 (enzastaurin) and temozolomide in patients with gliomas - EORTC trial 26054
    Rampling, R.
    Sanson, M.
    Taal, W.
    Lai, C.
    Stoffregen, C.
    Munoz, M.
    Gorlia, T.
    Govaerts, A.
    Lacombe, D.
    Van den Bent, M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [7] A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
    Kreisl, Teri N.
    Kotliarova, Svetlana
    Butman, John A.
    Albert, Paul S.
    Kim, Lyndon
    Musib, Luna
    Thornton, Donald
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2010, 12 (02) : 181 - 189
  • [8] A phase I/II trial of BMS-247550 for patients with recurrent high-grade gliomas.
    Peereboom, D
    Carson, K
    Lawson, D
    Lesser, G
    Supko, J
    Grossman, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 118S - 118S
  • [9] PHASE I TRIAL OF ENZASTAURIN (LY 317615) IN COMBINATION WITH CARBOPLATIN IN ADULTS WITH RECURRENT GLIOMA
    Ambady, Prakash
    Kreisl, Teri
    Warren, Katherine
    McNeill, Katherine
    Fine, Howard
    [J]. NEURO-ONCOLOGY, 2014, 16
  • [10] A phase I trial of intravenous liposomal irinotecan in patients with recurrent high-grade gliomas.
    Clarke, Jennifer Leigh
    Molinaro, Annette M.
    DeSilva, Ashley A.
    Rabbitt, Jane E.
    Drummond, Daryl C.
    Chang, Susan Marina
    Butowski, Nicholas A.
    Prados, Michael
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345